Navigation Links
Cholesterol-lowering therapy benefits older people also

According to a new study it is observed that statins reduce the risk of heart attack in older people. Long-term treatment with statins lowers cholesterol// levels and so lowers the risk of heart disease. This has been shown to be the case in middle-aged people, but the benefits for the elderly have not been so clear.

Researchers at the University of Glasgow have assessed the benefit of treatment with the statin drug pravastatin in a group of 4,050 men and women aged between 75 and 80 years, all at high risk of heart attack or stroke. Half received pravastatin and half a placebo and all were followed up for an average of just over three years.

Pravastatin lowered low density lipoprotein (LDL, or 'bad' cholesterol) by about a third, and reduced a combination of coronary death, non-fatal heart attack and stroke by 16 per cent. Closer analysis shows that death from heart disease was reduced by 20 per cent, while stroke risk was unaffected. Lucidly, people of all ages can benefit from long-term statin therapy. All patients at high risk of heart disease should now be offered statins to improve their survival and future health.


'"/>




Page: 1

Related medicine news :

1. Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
2. Growing Popularity of Cholesterol-lowering Drugs Raises Concern
3. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina ... of New York was founded by James M. Maisel, MD and has been providing tertiary ... has always followed a legacy of surpassing expectations amongst her peers. Growing up in ...
(Date:12/5/2016)... ... December 05, 2016 , ... Routine ... measurements are consistently correct. However, regular performance testing is often neglected because ... a solution: SmartCal™ . This innovative test substance offers a fast ...
(Date:12/5/2016)... ... December 05, 2016 , ... A newly released ... improves the reproducibility and accuracy of placing precordial electrodes with little cognitive effort ... the last 60 years, studies have shown that single electrode misplacement is one ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... transitions and many more tools allowing FCPX editors to create professional looking video ... Studios. , Perfect Harmony contains a beautifully designed 3D environment for placing ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior ... the Dallas area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ ... Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- PharmaBoardroom today releases its new 70 page Switzerland ... , ... investors, policymakers, and stakeholders crucial insight into Switzerland ; ... home to some of the world,s most important international health institutions as ... and with a number one ranking globally in terms of ease of ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... , Dec. 2, 2016  Former Attorney General of ... , a partner at the law firm of Kahn Swick ... investigation into Lannett Company, Inc. (NYSE: LCI ). ... published an article titled "U.S. Charges in Generic-Drug Probe to ... by the Justice Department, begun about two years ago, now ...
Breaking Medicine Technology: